In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Precigen Inc’s stock clocked out at $1.7, up 6.92% from its previous closing price of $1.59. In other words, the price has increased by $6.92 from its previous closing price. On the day, 1.74 million shares were traded. PGEN stock price reached its highest trading level at $1.71 during the session, while it also had its lowest trading level at $1.6.
Ratios:
To gain a deeper understanding of PGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 501806016 and an Enterprise Value of 373848672. For the stock, the TTM Price-to-Sale (P/S) ratio is 119.48. Its current Enterprise Value per Revenue stands at 88.99 whereas that against EBITDA is -4.185.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.85, which has changed by 0.10389614 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 17.59%, while the 200-Day Moving Average is calculated to be 33.93%.
Shares Statistics:
It appears that PGEN traded 1.67M shares on average per day over the past three months and 2088950 shares per day over the past ten days. A total of 295.14M shares are outstanding, with a floating share count of 146.38M. Insiders hold about 50.41% of the company’s shares, while institutions hold 27.32% stake in the company. Shares short for PGEN as of 1749772800 were 27281305 with a Short Ratio of 16.36, compared to 1747267200 on 28738310. Therefore, it implies a Short% of Shares Outstanding of 27281305 and a Short% of Float of 16.04.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The company has 2.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.37 and -$0.37 for the fiscal current year, implying an average EPS of -$0.37. EPS for the following year is $0.05, with 2.0 analysts recommending between $0.11 and -$0.01.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $21M, while the lowest revenue estimate was $2.84M, resulting in an average revenue estimate of $13.7M. In the same quarter a year ago, actual revenue was $3.92MBased on 3 analysts’ estimates, the company’s revenue will be $118.1M in the next fiscal year. The high estimate is $172.4M and the low estimate is $57.7M.
